Thousands of men battling prostate cancer are set to gain access to a life-extending drug on the NHS following a significant ...
NHS England has announced that men whose high-risk prostate cancer has not yet spread will be able to receive the drug, ...
The decision means Northern Ireland remains the only country in the UK where patients with this stage of prostate cancer are ...
In men with localized, intermediate-risk prostate cancer, stereotactic body radiation therapy (SBRT) was associated with less toxicity at 2 years but a higher rate of biochemical failure at 3 years ...
Doctor explains how to reduce your risk of prostate cancer through small lifestyle tweaks - Lifestyle is one of the few ...
News-Medical.Net on MSN
Study tests combined targeted radiopharmaceuticals and precision radiation for recurrent prostate cancer
Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have opened a clinical trial that will look at whether ...
The MarketWatch News Department was not involved in the creation of this content. Jordan joins ZERO Prostate Cancer as its newest Global Ambassador to help save lives and urge more men, especially ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback